Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

348 ARTÍCULOS , VIENDO DEL 46 AL 60

Could Aesthetic Surgery Impact Alzheimer's Risk?

Nahai F.

Aesthet Surg J. 2016 Jul;36(7):858-9. doi: 10.1093/asj/sjw039. Epub 2016 Feb 23.

A path analysis of patient dependence and caregiver burden in Alzheimer's disease

Garre-Olmo J, Vilalta-Franch J, Calvó-Perxas L, Turró-Garriga O, Conde-Sala L, López-Pousa S.

Int Psychogeriatr. 2016 Jul;28(7):1133-41. doi: 10.1017/S1041610216000223. Epub 2016 Mar 1.

Meaningful activities for improving the wellbeing of people with dementia: beyond mere pleasure to meeting fundamental psychological needs

Nyman SR, Szymczynska P.

Perspect Public Health. 2016 Mar;136(2):99-107. doi: 10.1177/1757913915626193.

Evaluation of a mobile team dedicated to behavioural disorders as recommended by the Alzheimer Cooperative Valuation in Europe joint action: observational cohort study

Krolak-Salmon P, Roubaud C, Finne-Soveri H, Riolacci-Dhoyen N, Richard G, Rouch I, Leperre-Desplanques A, Dauphinot V.

Eur J Neurol. 2016 May;23(5):979-88. doi: 10.1111/ene.12975. Epub 2016 Mar 6.

Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease

Pasquier F, Sadowsky C, Holstein A, Leterme Gle P, Peng Y, Jackson N, Fox NC, Ketter N, Liu E, Ryan JM; ACC-001 (QS-21) Study Team.

J Alzheimers Dis. 2016;51(4):1131-43. doi: 10.3233/JAD-150376.

Nutritional Status is Associated with Faster Cognitive Decline and Worse Functional Impairment in the Progression of Dementia: The Cache County Dementia Progression Study1

Sanders C, Behrens S, Schwartz S, Wengreen H, Corcoran CD, Lyketsos CG, Tschanz JT.

J Alzheimers Dis. 2016 Feb 27;52(1):33-42. doi: 10.3233/JAD-150528.

Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study

Florian H, Meier A, Gauthier S, Lipschitz S, Lin Y, Tang Q, Othman AA, Robieson WZ, Gault LM.

J Alzheimers Dis. 2016;51(4):1237-47. doi: 10.3233/JAD-150978.

Diabetes and Alzheimer's disease crosstalk

Baglietto-Vargas D, Shi J, Yaeger DM, Ager R, LaFerla FM.

Neurosci Biobehav Rev. 2016 May;64:272-87. doi: 10.1016/j.neubiorev.2016.03.005. Epub 2016 Mar 9.

Significant cognitive improvement with cholinesterase inhibition in AD with cerebral amyloid angiopathy

Paterson RW, Abdi Z, Haines A, Schott JM.

Clin Neurol Neurosurg. 2016 May;144:64-6. doi: 10.1016/j.clineuro.2016.02.036. Epub 2016 Mar 3.

Detection of Aβ Monomers and Oligomers: Early Diagnosis of Alzheimer's Disease

Zhou Y, Liu L, Hao Y, Xu M.

Chem Asian J. 2016 Mar 18;11(6):805-17. doi: 10.1002/asia.201501355. Epub 2016 Feb 4.

Advances in development of fluorescent probes for detecting amyloid-β aggregates

Xu MM, Ren WM, Tang XC, Hu YH, Zhang HY.

Acta Pharmacol Sin. 2016 Jun;37(6):719-30. doi: 10.1038/aps.2015.155. Epub 2016 Mar 21.

Transcranial direct current stimulation as a memory enhancer in patients with Alzheimer's disease: a randomized, placebo-controlled trial

Bystad M, Grønli O, Rasmussen ID, Gundersen N, Nordvang L, Wang-Iversen H, Aslaksen PM.

Alzheimers Res Ther. 2016 Mar 23;8(1):13. doi: 10.1186/s13195-016-0180-3.

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K, Broich K, Cavedo E, Crutch S, Dartigues JF, Duyckaerts C, Epelbaum S, Frisoni GB, Gauthier S, Genthon R, Gouw AA, Habert MO, Holtzman DM, Kivipelto M, Lista S, Molinuevo JL, O'Bryant SE, Rabinovici GD, Rowe C, Salloway S, Schneider LS, Sperling R, Teichmann M, Carrillo MC, Cummings J, Jack CR Jr; Proceedings of the Meeting of the International Working Group (IWG) and the American Alzheimer's Association on “The Preclinical State of AD”; July 23, 2015; Washington DC, USA.

Alzheimers Dement. 2016 Mar;12(3):292-323. doi: 10.1016/j.jalz.2016.02.002.

Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24-week, Randomized, Double-Blind Parallel-Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily)

Zhang ZX, Hong Z, Wang YP, He L, Wang N, Zhao ZX, Zhao G, Shang L, Weisskopf M, Callegari F, Strohmaier C.

CNS Neurosci Ther. 2016 Jun;22(6):488-96. doi: 10.1111/cns.12521. Epub 2016 Mar 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias